Evidence map›Paper›PMID 33903712›Full record

ArticleScientific reports2021

Suppression of human T cell activation by derivatives of glycerol monolaurate.

Micaela G Fosdick, Pratik Rajesh Chheda, Phuong M Tran, Alex Wolff, Ronal Peralta, Michael Y Zhang, Robert Kerns, Jon C D Houtman

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Glycerol monolaurate inhibitsmicroPublication biology · 2023
    Article
  6. Frontiers in veterinary science · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Micaela G FosdickBiomedical Sciences Graduate Program, Subprogram in Molecular Medicine, Carver College of Medicine, University of Iowa, 2110 MERF, Iowa City, IA, 52242, USA.
Pratik Rajesh ChhedaDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA.
Phuong M TranDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, USA.
Alex WolffDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, USA.
Ronal PeraltaDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, USA.
Michael Y ZhangDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, USA.
Robert KernsDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, USA.
Jon C D HoutmanBiomedical Sciences Graduate Program, Subprogram in Molecular Medicine, Carver College of Medicine, University of Iowa, 2110 MERF, Iowa City, IA, 52242, USA. Jon-houtman@uiowa.edu.
University of Iowa · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
Medical Scientist Training ProgramT32GM139776 · NIGMS · UNIVERSITY OF IOWA · PI Gordon F Buchanan · 2021 to 2026
$6.4M
RESEARCH TRAINING IN INFECTIOUS DISEASEST32AI007343 · NIAID · UNIVERSITY OF IOWA · PI STAPLETON, JACK T. · 1988 to 2024
$5.0M
The role of HCV RNA-targeted phosphatase PTPRE in T cell activationR56AI126493 · NIAID · UNIVERSITY OF IOWA · PI HOUTMAN, JON C.D., STAPLETON, JACK T. · 2017 to 2017
$538k
BLRD VA I01 BX000207NCI NIH HHS P30 CA086862NIAID NIH HHS R56 AI126493NIAID NIH HHS T32 AI007343NIGMS NIH HHS T32 GM007337NIGMS NIH HHS T32 GM139776
6 · The paper itself

Abstract

Glycerol monolaurate (GML), a naturally occurring monoglyceride, is widely used commercially for its antimicrobial properties. Interestingly, several studies have shown that GML not only has antimicrobial properties but is also an anti-inflammatory agent. GML inhibits peripheral blood mononuclear cell proliferation and inhibits T cell receptor (TCR)-induced signaling events. In this study, we perform an extensive structure activity relationship analysis to investigate the structural components of GML necessary for its suppression of human T cell activation. Human T cells were treated with analogs of GML, differing in acyl chain length, head group, linkage of acyl chain, and number of laurate groups. Treated cells were then tested for changes in membrane dynamics, LAT clustering, calcium signaling, and cytokine production. We found that an acyl chain with 12-14 carbons, a polar head group, an ester linkage, and a single laurate group at any position are all necessary for GML to inhibit protein clustering, calcium signaling, and cytokine production. Removing the glycerol head group or replacing the ester linkage with a nitrogen prevented derivative-mediated inhibition of protein cluster formation and calcium signaling, while still inhibiting TCR-induced cytokine production. These findings expand our current understanding of the mechanisms of action of GML and the of GML needed to function as a novel immunosuppressant.

Indexed as

Calcium SignalingHumansLauratesLymphocyte ActivationMonoglyceridesReceptors, Antigen, T-CellT-LymphocytesLauratesMonoglyceridesmonolaurinReceptors, Antigen, T-Cell

Identifiers

PMID33903712
PMCPMC8076190
OpenAlexW3157607105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.